Literature DB >> 29237547

Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?

Christopher D Byrne1, Gianluca Perseghin2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29237547     DOI： 10.1016/j.jhep.2017.12.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis.

Authors:  Haitao Pan; Chuhan Fu; Lanlan Huang; Yao Jiang; Xiaoyi Deng; Jiao Guo; Zhengquan Su
Journal:  Mar Drugs       Date:  2018-06-05       Impact factor: 5.118

2.  Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study.

Authors:  Ammar Salehi-Sahlabadi; Amin Mokari; Maryam Elhamkia; Fariba Farahmand; Masoumeh Jabbari; Azita Hekmatdost
Journal:  J Res Health Sci       Date:  2020-07-30

Review 3.  How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Authors:  Yana Geng; Klaas Nico Faber; Vincent E de Meijer; Hans Blokzijl; Han Moshage
Journal:  Hepatol Int       Date:  2021-02-06       Impact factor: 6.047
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.